Today's picks
Top candidates from last night's scan. Scores refresh each evening; prices are live.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Top candidates from last night's scan. Scores refresh each evening; prices are live.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
MEDINCELL S.A.
€26.76
Quality concerns: company is profitable, revenue is growing.
Chart by TradingView
Passed
13
Failed
11
R:R
0.43:1
Confidence
low
Entry €26.76
Stop loss €24.35
Target €27.80
Quality 4/35 (1/8 passed)
Technical 30/40 (6/8 passed)
Trade setup 8/15 (2/4 passed)
Red flags 7/10 (2/6 triggered — informational, gates only)
Conviction total 47/100 — quality + technical + trade setup only. Unknown rules count as not passed.
Status: Known upside
Technical target: €27.80
Analyst target: €34.90
Effective target: €27.80
R:R 0.43:1
Analyst target aligns with or is below technical upside.
Entry: €26.76
Stop loss: €24.35
Effective target: €27.80
Rule-based analysis generated by Huntover. Not financial advice.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Market cap is not tiny / speculative
Market cap is $1.0B.
Price above 50-day moving average
Price $26.76 is above 50-day MA $23.74.
Price above 200-day moving average
Price is above 200-day MA $24.74.
Price not near 52-week low
35.9% above 52-week low.
Stock is in an uptrend
Price up 1.1% over 20 days.
Recent volume above average
Volume is 6.10x the average.
Breaking above recent resistance
Price near/above recent resistance $24.44.
Clear entry price exists
Current price $26.76 can be used as entry reference.
Stop loss no more than 10% below entry
Suggested stop at $24.35 (9.0% below entry).
Price near 52-week low
Not near 52-week low.
Very low trading volume
Volume is not unusually low.
Recent large price drop
No recent large drop detected.
Missing too much data
5 data field(s) missing.
Company is profitable
Profit margin is -128.9% (not profitable).
Revenue is growing
Revenue is declining (-44.6%).
Free cash flow is positive
Free cash flow is negative.
Debt is manageable
Debt-to-equity is 2347.1% (elevated).
Return on equity or capital is positive
Both ROE and ROA are not positive.
Valuation is not extreme
P/E unknown, P/S 39.6.
50-day MA above 200-day MA
50-day MA is below 200-day MA.
Price near 52-week high
32.6% below 52-week high.
Spread / liquidity risk acceptable
Low average volume (65,101).
EPS / earnings are growing
Earnings growth data unavailable.
No earnings within 7 days
Earnings date unavailable.
Yahoo Finance did not return these inputs, so related rules may be marked unknown.
Very high debt
Debt-to-equity 2347.1% is very high.
Extreme valuation
Extreme valuation (P/E —, P/S 39.6).
